Compare RCUS & ATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RCUS | ATS |
|---|---|---|
| Founded | 2015 | 1978 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2018 | 2023 |
| Metric | RCUS | ATS |
|---|---|---|
| Price | $22.00 | $30.76 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | $28.89 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 1.6M | 93.8K |
| Earning Date | 02-24-2026 | 02-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $240,000,000.00 | ★ $1,930,283,080.00 |
| Revenue This Year | N/A | $16.92 |
| Revenue Next Year | N/A | $5.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.50 | $20.90 |
| 52 Week High | $26.40 | $32.73 |
| Indicator | RCUS | ATS |
|---|---|---|
| Relative Strength Index (RSI) | 47.16 | 69.94 |
| Support Level | $20.59 | $28.18 |
| Resistance Level | $23.40 | $31.03 |
| Average True Range (ATR) | 1.39 | 0.77 |
| MACD | -0.07 | 0.18 |
| Stochastic Oscillator | 32.38 | 90.58 |
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.